Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Eisai Co. Ltd.
DescriptionHumanized mAb against tissue factor
Molecular Target Tissue factor (TF) (CD142) (thromboplastin)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard IndicationPancreatic cancer
Indication DetailsTreat pancreatic cancer
Regulatory Designation U.S. - Orphan Drug (Treat pancreatic cancer)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today